[Form 4] IDEXX LABORATORIES INC /DE Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
IDEXX Laboratories Executive Vice President George Fennell reported a series of routine equity compensation transactions. On February 12, 2026, he received grants of 3,384 non-qualified stock options, 162 incentive stock options, and 810 restricted stock units (RSUs), each representing the right to receive one share of common stock as they vest over future years.
On February 14, 2026, previously granted RSUs vested and were converted into common shares through derivative exercises, and 199 common shares were withheld at $629.35 per share to satisfy tax obligations. After these transactions, Fennell directly held 10,078 shares of IDEXX common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
454 shares exercised/converted
Mixed
12 txns
Insider
FENNELL GEORGE
Role
Executive Vice President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 55 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 56 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 139 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 204 | $0.00 | -- |
| Exercise | Common Stock | 55 | $0.00 | -- |
| Exercise | Common Stock | 56 | $0.00 | -- |
| Exercise | Common Stock | 139 | $0.00 | -- |
| Exercise | Common Stock | 204 | $0.00 | -- |
| Tax Withholding | Common Stock | 199 | $629.35 | $125K |
| Grant/Award | Non-Qualified Stock Option (right-to-buy) | 3,384 | $0.00 | -- |
| Grant/Award | Incentive Stock Option (right-to-buy) | 162 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 810 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct);
Common Stock — 9,878 shares (Direct);
Non-Qualified Stock Option (right-to-buy) — 3,384 shares (Direct);
Incentive Stock Option (right-to-buy) — 162 shares (Direct)
Footnotes (1)
- Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026. Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030. Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock that vests in four annual installments, beginning February 14, 2027. Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments beginning February 14, 2023. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning February 14, 2024. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026.
